Invesco
FENC icon

Invesco’s Fennec Pharmaceuticals FENC Stock Holding History

Invesco’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$169K Buy
15,744
+4,067
+35% +$33.2K ﹤0.01% 3632
2026
Q1 		$71.8K Sell
11,677
-2,651
-19% -$20.5K ﹤0.01% 3662
2025
Q4 		$110K Buy
14,328
+2,201
+18% +$18.1K ﹤0.01% 3624
2025
Q3 		$114K Buy
12,127
+767
+7% +$6.64K ﹤0.01% 3666
2025
Q2 		$94.3K Buy
+11,360
New +$77.7K ﹤0.01% 3659
2021
Q2 		– Sell
-12,818
Closed -$80K – 3983
2021
Q1 		$80K Buy
12,818
+2,685
+26% +$20.2K ﹤0.01% 3784
2020
Q4 		$75K Buy
+10,133
New +$77.2K ﹤0.01% 3684

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Invesco's FENC Position: Q2 2026 in Review

Invesco increased its Fennec Pharmaceuticals (FENC) stake by 35% in Q2 2026, buying an estimated $33.2K and bringing the position to 15,744 shares worth $169K. The position accounts for ﹤0.01% of the portfolio, ranked #3632.

Invesco first reported a position in FENC in Q4 2020 and has held it in 7 quarters since. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Invesco held 15,744 shares of Fennec Pharmaceuticals worth $169K as of Q2 2026.
  • Invesco bought 4,067 Fennec Pharmaceuticals shares in Q2 2026, an estimated $33.2K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3632 holding.
  • Invesco first reported a position in Fennec Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.